CIK 0001533040 · Non-accelerated filer<br>Smaller reporting company
Phio Pharmaceuticals Corp.
Sign in to watch- Ticker
- PHIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 453215903
- Phone
- (508) 767-3861
- Business address
- 411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
- Former names
- RXi Pharmaceuticals Corp
- 4 Open-market buy President & CEO bought 1,000 shares at $2.50 ($2,500)
- 4 Open-market buy President & CEO bought 1,400 shares at $2.57 ($3,598)
- 4 Open-market buy President & CEO bought 2,000 shares at an average $2.86 ($5,713)
- 4 Open-market buy President & CEO bought 500 shares at $3.01 ($1,505)
- 4 Open-market buy President & CEO bought 2,000 shares at an average $2.98 ($5,960)
- 4 Open-market buy President & CEO bought 1,000 shares at an average $3.05 ($3,050)
- 4 Open-market buy President & CEO bought 2,000 shares at an average $2.94 ($5,886)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 11 of 15 · 281 filings